The EPAA aims to replace animal testing by innovative, non-animal testing methods, to reduce the number of animals used and to refine procedures where no alternatives exist or are not sufficient to ensure the safety of substances (the '3R principle'). The partners are pooling knowledge and resources to accelerate the development, validation and acceptance of alternative approaches at national, European and global levels.
The EPAA seeks to bridge the knowledge gap and to facilitate coordination and cooperation via its partners and project platform. It promotes the results via its various European and international activities and events, its annual conference and via its awards and grants that are particularly addressed to young scientists.
Watch the video on the EPAA
EPAA is on Twitter and LinkedIn
Launched in November 2005 with the support of European Commissioners Verheugen and Potocnik, the EPAA began operations in 2006. It completed a first mandate of 5 years by the end of 2010.
Due to the encouraging results of the EPAA's projects, the mandate has been renewed for 5-year terms since. Priorities of the second mandate included integrated testing strategies (lead theme 2011), and international collaboration on 3Rs (lead theme 2012-2013).
The new action programme 2021-2025 (92 kB) focuses on facilitating regulatory acceptance.
The vision of EPAA is the replacement, reduction and refinement (3Rs) of animal use for meeting regulatory requirements through better and more predictive science.
The EPAA vision and mission paper (340 kB)
We value your privacy. See the EPAA privacy statement on the protection of your personal data.
Disclaimer: This webpage contains information on past events, such as agendas of annual meetings or workshops, which may contain the names of speakers. If your name is mentioned and you would like us to remove it, please contact GROW-EPAA@ec.europa.eu.